WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 41'087  40'729  40'374  40'024  39'676  36'903  32'625  28'120 
Births 695  695  694  693  691  691  709  692 
Surviving infants 687  687  686  684  682  678  691  668 
Pop. less than 5 years 3'436  3'422  3'384  3'365  3'340  3'449  3'395  3'330 
Pop. less than 15 years 10'049  10'052  10'044  10'067  10'088  10'305  10'014  8'574 
Female 15-49 years 10'372  10'276  10'182  10'084  9'986  9'142  7'767  6'758 

Number of reported case

(Click for retrospective incidence data for Argentina)
Diphtheria 31  86 
Japanese encephalitis
Measles 17  1'967  16'102 
Mumps 4'619  5'481  5'083  5'913  12'198 
Pertussis 1'239  1'594  804  1'743  3'085  515  2'012  27'223 
Polio* 32 
Rubella 2'252 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 10  15  12  49  219 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Argentina)
Vaccine year result method % card seen                                                
BCG          100  99*  100  100  99*  99  99*  62 
DTP1          94  94  95  94  97  88 
DTP3          91  93  94  94  94  83  87  44 
HepB_BD          88  85  85  81  80 
HepB3          91  93  94  93  90 
Hib3          91  93  94  93  90  83 
JapEnc         
MCV          94  95  99*  100  96  91  93  61 
MCV2          90  91  96  96  86  91 
PCV1          69 
PCV3          22 
Pol3          90  93  95  97  94  88  90  33 
Rota1         
Rota_last         
Rubella1          94  95  99  100  97 
TT2plus          78  42 
PAB         
VAD1         
YFV          88  87  90  89 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Argentina)
BCG 99  99  99  99  99  99  99  62 
DTP1 94  94  95  94  97  96  95  69 
DTP3 91  92  94  94  94  83  87  44 
HepB3 91  92  94  93  90 
Hib3 91  92  94  93  90  83 
MCV 94  95  98  99  96  91  93  61 
PCV3 22 
Pol3 90  93  95  97  94  88  90  33 
Rota_last
YFV 12  14 

Number of districts in the country 511  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 58
From 80 to 89% 26
From 50 to 79% 13
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth; Yes
DTaPHibHepIPV Yes From February 2013 for premature babies <1500g
DTwP 6 years; Yes
DTwPHiB 18 months; Yes
DTwPHibHep 2, 4, 6 months; Yes
HIB Yes risk groups
HPV 11 years (x3) Yes
HepA 12 months; Yes
HepB birth; Yes Y11 school children if not yet vaccinated and adults
IPV Yes risk groups
Influenza 6, 7 months; >= 65 years; Yes PW and risk groups
MMR 1, 6 years; Yes and Y11 if not yet vaccinated
MR Yes postpartum and postabortum
MenACWY Yes risk groups
OPV 2, 4, 6, 18 months; 6 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps > 65 years; and risk groups
Td 16 years; Yes
Tdap 11 years; Yes HCW and PW
Varicella risk groups
YF 12 months; No risk areas

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2010-2015  2012-2016  2010-2015  2006-2010  2006-2010  2006-2010   
Nº of districts with microplans that include activities to raise immunization coverage number 24  129    24  24    24 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 511    511  511  547  547  548 
Nº districts with DTP3 coverage >=80% number 430    349  427    463  435 
% of districts with DTP3 coverage >=80% From 0 to 100% 84    68  84    85  79 
Nº districts with measles (MCV1) coverage >=95% number 270  254  259  313       
% of districts with MCV1 coverage >=95% From 0 to 100% 53    51  61       

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100        100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.